Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock
- 1 March 1987
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 135 (2), 117-122
- https://doi.org/10.1016/0014-2999(87)90602-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.Journal of Clinical Investigation, 1985
- Is platelet activating factor (PAF) a mediator of endotoxin shock?European Journal of Pharmacology, 1985
- Structural identification of platelet activating factor in psoriatic scaleBiochemical and Biophysical Research Communications, 1985
- Change in membrane lipid fluidity induced by phospholipase a activation: A mechanism of endotoxic shockLife Sciences, 1983
- BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)Annals of the New York Academy of Sciences, 1981
- Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissuesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Platelet-activating factor (PAF-acether) and macrophagesCellular Immunology, 1981
- Elevated Thromboxane Levels in the Rat during Endotoxic ShockJournal of Clinical Investigation, 1980
- Unilateral Shwartzman reaction: Cortical necrosis in one kidney following in vivo perfusion with endotoxinKidney International, 1977
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972